Our Company

OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.

Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has 65+ employees and is listed on Euronext Paris.


Corporate presentation

Breaking through the therapeutic ceiling with first-in-class immunotherapies


Download our Corporate Presentation

Presentation post-ASCO 2022

ASCO results & Tedopi® update, June 7th 2022

Download our Presentation post-ASCO 2022

Half-year results 2022

23rd September 2022

Upload our Half-year Results Presentation

Management team

The Company relies upon its international and complementary team of experts involved in the research and optimisation of drug candidates, pharmaceutical development and drug registration to develop the next wave of novel immunotherapies.

Board of Directors

Members of the Board of Directors combine international expertise in both drug development, marketing, industry and finance, with experience in listed biotech companies.


To receive OSE Immunotherapeutics’ latest news

[sibwp_form id=3]